Predictive biosimulation company working with pharmaceutical and biotechnology research and development teams, whose software platform builds mechanistic models of human physiology and disease to create virtual patients. Uses those models to simulate drug effects, explore dose and trial design, prioritise targets and support clinical trial planning across therapeutic areas including metabolic, cardiovascular, immunological and inflammatory disease.
コメントはありません。
評価とコメントを残す